Loading...
Domestic
Equity
Passive

RISE Healthcare (253280)

Update : 2026.10.16

NAV

11,885KRW

-0.04하락 (-%)

Market Price per share (KRW)

11,835KRW

+585상승 (5.2%)

※ t-1 last price

trading volume

391shares

AUM

KRW 7.1billion

RISE Healthcare (253280)

KEY POINT

Invest in domestic healthcare companies (medical equipment and services, bio, pharmaceutical)

KEY POINT

Invest in selected healthcare companies based on financial conditions among the top 500 companies by market capitalization of the KOSPI and KOSDAQ markets

Basic information

Download trading information

Update : 2026.10.16
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB RISE HealthCare ETF
(253280)
FnGuide HealthCare Index 2016.09.23 50,000 7,130,799,691
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 11,835
※ t-1 last price
11,884 391
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%) Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB RISE HealthCare ETF

(253280)
FnGuide HealthCare Index
Inception date Creation Unit
2016.09.23 50,000
AUM(0.1 billion) (KRW) Trustee
7,130,799,691 하나은행
Market Price per share (KRW) iNAV per share (KRW)
11,835
※ t-1 last price
11,884
Trading Volume (shares)
391
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%)
Distribution Frequency
Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Index is a market capitalization weighted index. The index selects stocks that satisfy financial and management soundness criteria out of the universe of stocks come under the medical sector in the MKF 500.

View detailed index information

TOP 10 Holdings

Update : 2026-10-16
Rank , Name, proportion table
Rank Name Weight (%)
1 Celltrion 13.16
2 SAMSUNG BIOLOGICS 11.54
3 Alteogen 9.62
4 HLB 7.47
5 Yuhan 6.54
6 SKBP 4.30
7 SCD 4.15
8 HanmiPharm 3.78
9 SAMSUNG EPIS HOLDINGS 3.09
10 PharmaResearch 2.67

proportion by sectors

*The proportion of investment stocks

Update : 2026.10.16
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2026-04-30 2026-05-06 25
2025-04-30 2025-05-07 20
2023-04-28 2023-05-03 16
2022-04-29 2022-05-03 60

Performance

performance

excel download

Update : 2026-10-16

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)
Since
inception
NAV -1.96 -3.24 -31.82 -18.93 10.23 -29.31 17.35
Benchmark Index -2.04 -3.29 -32.28 -19.35 9.86 -29.79 17.53
Outperformance 0.08 0.04 0.46 0.42 0.37 0.48 -0.18

daily Performance

excel download

date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW) Standard Tax Base Price (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2026.10.16 11,835 5.200상승 11,884.71 5.786상승 10,354.51
2026.10.15 11,250 -1.445하락 11,234.59 -1.433하락 10,354.55
2026.10.14 11,415 -0.911하락 11,398 -1.333하락 10,355.74
2026.10.13 11,520 -1.957하락 11,552.02 -1.618하락 10,355.78
2026.10.12 11,750 -2.691하락 11,742.09 -2.837하락 10,355.83
2026.10.08 12,075 -3.784하락 12,085.15 -3.641하락 10,355.97
2026.10.07 12,550 -0.947하락 12,541.8 -0.552하락 10,356
2026.10.06 12,670 2.966상승 12,611.45 2.695상승 10,356.05
2026.10.02 12,305 -1.243하락 12,280.55 -1.694하락 10,356.23
2026.10.01 12,460 3.359상승 12,492.27 3.747상승 10,356.28
2026.09.30 12,055 0.626상승 12,041.02 0.274상승 10,356.33
2026.09.29 11,980 -0.498하락 12,008.07 -0.150하락 10,356.37
2026.09.28 12,040 2.555상승 12,026.22 2.108상승 10,353.89
2026.09.23 11,740 -0.550하락 11,778.09 -0.185하락 10,354.12
2026.09.22 11,805 -1.501하락 11,800 -1.391하락 10,354.17
2026.09.21 11,985 0.461상승 11,966.53 0.434상승 10,354.21
2026.09.18 11,930 -1.118하락 11,914.88 -1.707하락 10,354.35

Holdings

Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares Weight(%) Market price (KRW)
1 Celltrion KR7068270008 406 13.16 73,932,600
2 SAMSUNG BIOLOGICS KR7207940008 52 11.54 64,844,000
3 Alteogen KR7196170005 253 9.62 54,015,500
4 HLB KR7028300002 1,030 7.47 41,972,500
5 Yuhan KR7000100008 481 6.54 36,748,400
6 SKBP KR7326030004 348 4.3 24,151,200
7 SCD KR7000250001 121 4.15 23,316,700
8 HanmiPharm KR7128940004 55 3.78 21,230,000
9 SAMSUNG EPIS HOLDINGS KR70126Z0002 57 3.09 17,385,000
10 PharmaResearch KR7214450009 58 2.67 14,993,000
11 ABL Bio KR7298380007 368 2.66 14,922,400
12 LCB KR7141080002 230 2.57 14,444,000
13 HANALL BIOPHARMA KR7009420001 306 2.23 12,515,400
14 L&C BIO KR7290650001 180 1.82 10,206,000
15 SEEGENE KR7096530001 278 1.78 9,994,100
16 ST Pharm KR7237690003 113 1.69 9,469,400
17 SKBS KR7302440003 230 1.45 8,130,500
18 Hanmi Science KR7008930000 176 1.42 7,999,200
19 Hugel KR7145020004 46 1.38 7,751,000
20 Lunit KR7328130000 608 1.19 6,712,320
21 Celltrionph KR7068760008 178 1.16 6,505,900
22 CLASSYS KR7214150005 232 1.13 6,322,000
23 원화예금 KRD010010001 6,312,456 1.12 6,312,456
24 GC Biopharma Corp. KR7006280002 48 1.07 6,000,000
25 Pharmicell KR7005690003 485 0.9 5,029,450
26 DongKook Pharm KR7086450004 205 0.9 5,063,500
27 CHONGKUNDANG KR7185750007 69 0.82 4,588,500
28 HK inno.N KR7195940002 123 0.76 4,280,400
29 DAEWOONG PHARM KR7069620003 39 0.73 4,095,000
30 CHA Biotech KR7085660009 520 0.68 3,832,400
31 HLBPHARMA KR7047920004 321 0.6 3,376,920
32 ShinpoongPharm KR7019170000 345 0.57 3,174,000
33 MedyTox KR7086900008 47 0.54 3,040,900
34 i-SENS KR7099190001 189 0.53 2,967,300
35 JWPHARMA KR7001060003 116 0.5 2,830,400
36 ORUM KR7475830006 161 0.46 2,579,220
37 ILDONG PHARM KR7249420001 183 0.42 2,353,380
38 EuBio KR7206650004 271 0.38 2,108,380
39 DENTIUM KR7145720009 57 0.38 2,137,500
40 T&L KR7340570001 79 0.35 1,978,950
41 CUREXO KR7060280005 253 0.33 1,831,720
42 GC Corp. KR7005250006 188 0.3 1,712,680
43 WONTECH KR7336570007 374 0.29 1,634,380
44 Binex KR7053030003 250 0.26 1,435,000
45 Huons Global KR7084110006 47 0.18 1,001,100
46 KLS KR7102940004 65 0.14 804,700
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.